EBI3 and gastric cancer: While rhIL-35 did not directly impact the angiogenesis of HUVEC in vitro tube-forming assays, the supernatant from gastric cancer cells overexpressing IL-35, EBI3, and IL-12A notably enhanced HUVEC angiogenesis.